 Akero wowed investors Tuesday with midstage test results for a hepatitis treatment, and the biotech stock skyrocketed by triple digits. The post Akero Therapeutics Wows Investors With Unexpected Win For Hepatitis Treatment appeared first on Investors Business Daily. 